The drug screening market is expected to grow by USD 6,659.87 millionduring the five-year forecast period, according to Technavio. As per the latest report, the market will progress at a CAGR of 16.97% during 2022-2027. The integration of artificial intelligence (AI) and machine learning (ML) in drug screening is a major trend in the market. Drug screening processes are improved in accuracy, efficiency, and reliability using AI and ML algorithms. Using these systems, huge volumes of data and spot trends could be examined that could indicate drug use, producing more accurate results. Additionally, AI-based software can easily simplify data management and reporting, optimize overall workflow, and make drug trial decision-making smoother with AI. Hence, the integration of artificial intelligence (AI) and machine learning (ML) is expected to drive the growth of the market during the forecast period. View the new Sample Report within minutes!
Drug Screening Market 2023-2027: Scope
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. Our drug screening market report covers the following areas:
- Drug Screening Market size
- Drug Screening Market Trends
- Drug Screening Market industry analysis
- Drug Screening Market five forces analysis
- Drug Screening Market Competitive Landscape
Drug Screening Market 2023-2027: Market Dynamics
Key Drivers
The advancements in drug screening technologies are a key factor driving market growth. Drug sensitivity, specificity, and efficacy are factors driving innovation and advancement in testing equipment and procedures. Furthermore, through the incorporation of advanced analytical techniques such as liquid chromatography-mass spectrometry (LC-MS), the identification and quantification of drug compounds is accomplished. Drug dependence allows for better identification of a wide variety of substances and their metabolites due to these developments. Hence, advancements in drug screening technologies are expected to drive the growth of the market during the forecast period.
Significant Challenges
The development of alternative testing methods is a significant challenge restricting market growth. Sweat patch testing, oral fluid testing, and hair follicle testing are alternatives to traditional techniques. Furthermore, it challenges companies to make the necessary investments in alternative technologies to meet changing consumer preferences. In addition, changes to the existing regulatory framework and standardized process may be required to allow the use of alternative testing methods. Hence, the development of alternative testing methods is expected to restrict the growth of the market during the forecast period.
Drug Screening Market 2023-2027: SegmentationDrug Screening Market is segmented as below:
- Type
- Drug Screening Products
- Drug Screening Services
- Application
- Urine Samples
- Breath Samples
- Hair And Blood Samples
- Oral Fluid Samples
- Geography
- North America
- Europe
- Asia
- Rest Of World (ROW)
The market share growth by the drug screening products segment will be significant during the forecast period. This segment includes test kits, analyzers, and consumables, and these are widely used for drug testing purposes. Demand for these items is steadily increasing due to increased drug abuse, tight restrictions, and concerns about worker safety. In addition, the demand for drug screening products has increased as the development of technology has developed more reliable drug screening solutions. Hence, these factors are expected to drive the growth of the segment during the forecast period.
What’s New? –
- Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
- Global competitiveness and key competitor positions
- Market presence across multiple geographical footprints – Strong/Active/Niche/Trivial – Buy the report!
Drug Screening Market 2023-2027: Company Analysis
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. We provide a detailed analysis of around 25 companies operating in the Drug Screening Market, including Abbott Laboratories, Alfa Scientific Designs Inc, bioMerieux SA, Bio Rad Laboratories Inc., Bombardier Recreational Products Inc., Dragerwerk AG and Co. KGaA, F. Hoffmann La Roche Ltd., Healgen Scientific, LLC, Laboratory Corp. of America Holdings, Lifeloc Technologies Inc., LINEAR CHEMICALS S.L.U, Lochness Medical Supplies Inc., Omega Laboratories, Inc., OraSure Technologies Inc., Premier Biotech Inc., Psychemedics Corp., Quest Diagnostics Inc., Shimadzu Corp., Siemens AG, and Thermo Fisher Scientific Inc. are some of the major market participants. Our research reports on the Drug Screening Market are designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.
Company Offering
- Alfa Scientific Designs Inc – The company offers drug screening such as drug testing which provides saliva, urine CUPs, and single-drug urine tests.
- Abbott Laboratories – The company offers drug screening such as drug testing kits and devices.
- Dragerwerk AG and Co. KGaA – The company offers drug screening such as Drager drug test 5000 which is carried out simply and quickly.
Drug Screening Market 2023-2027: Key Highlights
- CAGR of the market during the forecast period 2023-2027
- Detailed information on factors that will assist drug screening market growth during the next five years
- Estimation of the drug screening market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the drug screening market
- Analysis of the market’s competitive landscape and detailed information on companies
- Comprehensive details of factors that will challenge the growth of drug screening market companies
Gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
Related Reports
The companion diagnostics market is estimated to grow at a CAGR of 22.59% between 2022 and 2027. The market size is forecast to increase by USD 11,029.63 million. Furthermore, this report extensively covers market segmentation by end-user (life science, health centers, and others), indication (oncology, neurology, and others), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The rising use of personalized medicine is a key factor driving market growth during the forecast period.
The cancer diagnostics market is estimated to grow at a CAGR of 11.3% between 2022 and 2027. The market size is forecast to increase by USD 12,626.21 million. Furthermore, this report extensively covers market segmentation by end-user (hospitals and clinics, and diagnostic laboratories), type (IVD, imaging, and IDT), and geography (North America, Europe, APAC, and the Rest of the World (ROW)). The high prevalence of cancer is a key factor driving market growth during the forecast period.
| Drug Screening Market Scope | |
| Report Coverage | Details |
| Base year | 2022 |
| Historic period | 2017-2021 |
| Forecast period | 2023-2027 |
| Growth momentum & CAGR | Accelerate at a CAGR of 16.97% |
| Market growth 2023-2027 | USD 6,659.87 million |
| Market structure | Fragmented |
| YoY growth 2022- 2023 (%) | 15.64 |
| Regional analysis | North America, Europe, Asia, and the Rest of the World (ROW) |
| Performing market contribution | North America at 44% |
| Key countries | US, Canada, Germany, China, and Japan |
| Competitive landscape | Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
| Key companies profiled | Abbott Laboratories, Alfa Scientific Designs Inc, bioMerieux SA, Bio Rad Laboratories Inc., Bombardier Recreational Products Inc., Dragerwerk AG and Co. KGaA, F. Hoffmann La Roche Ltd., Healgen Scientific, LLC, Laboratory Corp. of America Holdings, Lifeloc Technologies Inc., LINEAR CHEMICALS S.L.U, Lochness Medical Supplies Inc., Omega Laboratories, Inc., OraSure Technologies Inc., Premier Biotech Inc., Psychemedics Corp., Quest Diagnostics Inc., Shimadzu Corp., Siemens AG, and Thermo Fisher Scientific Inc. |
| Market dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
| Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table Of Contents :
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of companies included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global drug screening market 2017 – 2021
- Exhibit 18: Historic Market Size – Data Table on global drug screening market 2017 – 2021 ($ million)
- 4.2 Type Segment Analysis 2017 – 2021
- Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
- 4.3 Application Segment Analysis 2017 – 2021
- Exhibit 20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 – 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
- 4.5 Country Segment Analysis 2017 – 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Type
- 6.1 Market segments
- Exhibit 30: Chart on Type – Market share 2022-2027 (%)
- Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
- 6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type
- 6.3 Drug screening products – Market size and forecast 2022-2027
- Exhibit 34: Chart on Drug screening products – Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Drug screening products – Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Drug screening products – Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Drug screening products – Year-over-year growth 2022-2027 (%)
- 6.4 Drug screening services – Market size and forecast 2022-2027
- Exhibit 38: Chart on Drug screening services – Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Drug screening services – Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Drug screening services – Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Drug screening services – Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Type
- Exhibit 42: Market opportunity by Type ($ million)
- Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application
- 7.1 Market segments
- Exhibit 44: Chart on Application – Market share 2022-2027 (%)
- Exhibit 45: Data Table on Application – Market share 2022-2027 (%)
- 7.2 Comparison by Application
- Exhibit 46: Chart on Comparison by Application
- Exhibit 47: Data Table on Comparison by Application
- 7.3 Urine samples – Market size and forecast 2022-2027
- Exhibit 48: Chart on Urine samples – Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Data Table on Urine samples – Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Urine samples – Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Urine samples – Year-over-year growth 2022-2027 (%)
- 7.4 Breath samples – Market size and forecast 2022-2027
- Exhibit 52: Chart on Breath samples – Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Breath samples – Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Breath samples – Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Breath samples – Year-over-year growth 2022-2027 (%)
- 7.5 Hair and blood samples – Market size and forecast 2022-2027
- Exhibit 56: Chart on Hair and blood samples – Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Data Table on Hair and blood samples – Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on Hair and blood samples – Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on Hair and blood samples – Year-over-year growth 2022-2027 (%)
- 7.6 Oral fluid samples – Market size and forecast 2022-2027
- Exhibit 60: Chart on Oral fluid samples – Market size and forecast 2022-2027 ($ million)
- Exhibit 61: Data Table on Oral fluid samples – Market size and forecast 2022-2027 ($ million)
- Exhibit 62: Chart on Oral fluid samples – Year-over-year growth 2022-2027 (%)
- Exhibit 63: Data Table on Oral fluid samples – Year-over-year growth 2022-2027 (%)
- 7.7 Market opportunity by Application
- Exhibit 64: Market opportunity by Application ($ million)
- Exhibit 65: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 67: Chart on Market share by geography 2022-2027 (%)
- Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison
- 9.3 North America – Market size and forecast 2022-2027
- Exhibit 71: Chart on North America – Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on North America – Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on North America – Year-over-year growth 2022-2027 (%)
- 9.4 Europe – Market size and forecast 2022-2027
- Exhibit 75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Europe – Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
- 9.5 Asia – Market size and forecast 2022-2027
- Exhibit 79: Chart on Asia – Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Asia – Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on Asia – Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
- Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
- 9.7 US – Market size and forecast 2022-2027
- Exhibit 87: Chart on US – Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on US – Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on US – Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on US – Year-over-year growth 2022-2027 (%)
- 9.8 Germany – Market size and forecast 2022-2027
- Exhibit 91: Chart on Germany – Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on Germany – Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on Germany – Year-over-year growth 2022-2027 (%)
- 9.9 China – Market size and forecast 2022-2027
- Exhibit 95: Chart on China – Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on China – Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on China – Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on China – Year-over-year growth 2022-2027 (%)
- 9.10 Japan – Market size and forecast 2022-2027
- Exhibit 99: Chart on Japan – Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on Japan – Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
- 9.11 Canada – Market size and forecast 2022-2027
- Exhibit 103: Chart on Canada – Market size and forecast 2022-2027 ($ million)
- Exhibit 104: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
- Exhibit 105: Chart on Canada – Year-over-year growth 2022-2027 (%)
- Exhibit 106: Data Table on Canada – Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ million)
- Exhibit 108: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Company Landscape
- 11.1 Overview
- 11.2 Company landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 112: Impact of key risks on business
12 Company Analysis
- 12.1 Companies covered
- Exhibit 113: Companies covered
- 12.2 Market positioning of companies
- Exhibit 114: Matrix on company position and classification
- 12.3 Abbott Laboratories
- Exhibit 115: Abbott Laboratories – Overview
- Exhibit 116: Abbott Laboratories – Business segments
- Exhibit 117: Abbott Laboratories – Key news
- Exhibit 118: Abbott Laboratories – Key offerings
- Exhibit 119: Abbott Laboratories – Segment focus
- 12.4 Alfa Scientific Designs Inc
- Exhibit 120: Alfa Scientific Designs Inc – Overview
- Exhibit 121: Alfa Scientific Designs Inc – Product / Service
- Exhibit 122: Alfa Scientific Designs Inc – Key offerings
- 12.5 Dragerwerk AG and Co. KGaA
- Exhibit 123: Dragerwerk AG and Co. KGaA – Overview
- Exhibit 124: Dragerwerk AG and Co. KGaA – Business segments
- Exhibit 125: Dragerwerk AG and Co. KGaA – Key offerings
- Exhibit 126: Dragerwerk AG and Co. KGaA – Segment focus
- 12.6 F. Hoffmann La Roche Ltd.
- Exhibit 127: F. Hoffmann La Roche Ltd. – Overview
- Exhibit 128: F. Hoffmann La Roche Ltd. – Business segments
- Exhibit 129: F. Hoffmann La Roche Ltd. – Key news
- Exhibit 130: F. Hoffmann La Roche Ltd. – Key offerings
- Exhibit 131: F. Hoffmann La Roche Ltd. – Segment focus
- 12.7 Healgen Scientific, LLC
- Exhibit 132: Healgen Scientific, LLC – Overview
- Exhibit 133: Healgen Scientific, LLC – Product / Service
- Exhibit 134: Healgen Scientific, LLC – Key offerings
- 12.8 Laboratory Corp. of America Holdings
- Exhibit 135: Laboratory Corp. of America Holdings – Overview
- Exhibit 136: Laboratory Corp. of America Holdings – Business segments
- Exhibit 137: Laboratory Corp. of America Holdings – Key news
- Exhibit 138: Laboratory Corp. of America Holdings – Key offerings
- Exhibit 139: Laboratory Corp. of America Holdings – Segment focus
- 12.9 Lifeloc Technologies Inc.
- Exhibit 140: Lifeloc Technologies Inc. – Overview
- Exhibit 141: Lifeloc Technologies Inc. – Business segments
- Exhibit 142: Lifeloc Technologies Inc. – Key offerings
- Exhibit 143: Lifeloc Technologies Inc. – Segment focus
- 12.10 LINEAR CHEMICALS S.L.U
- Exhibit 144: LINEAR CHEMICALS S.L.U – Overview
- Exhibit 145: LINEAR CHEMICALS S.L.U – Product / Service
- Exhibit 146: LINEAR CHEMICALS S.L.U – Key offerings
- 12.11 Lochness Medical Supplies Inc.
- Exhibit 147: Lochness Medical Supplies Inc. – Overview
- Exhibit 148: Lochness Medical Supplies Inc. – Product / Service
- Exhibit 149: Lochness Medical Supplies Inc. – Key offerings
- 12.12 Omega Laboratories, Inc.
- Exhibit 150: Omega Laboratories, Inc. – Overview
- Exhibit 151: Omega Laboratories, Inc. – Product / Service
- Exhibit 152: Omega Laboratories, Inc. – Key offerings
- 12.13 OraSure Technologies Inc.
- Exhibit 153: OraSure Technologies Inc. – Overview
- Exhibit 154: OraSure Technologies Inc. – Business segments
- Exhibit 155: OraSure Technologies Inc. – Key offerings
- Exhibit 156: OraSure Technologies Inc. – Segment focus
- 12.14 Premier Biotech Inc.
- Exhibit 157: Premier Biotech Inc. – Overview
- Exhibit 158: Premier Biotech Inc. – Product / Service
- Exhibit 159: Premier Biotech Inc. – Key offerings
- 12.15 Psychemedics Corp.
- Exhibit 160: Psychemedics Corp. – Overview
- Exhibit 161: Psychemedics Corp. – Product / Service
- Exhibit 162: Psychemedics Corp. – Key offerings
- 12.16 Quest Diagnostics Inc.
- Exhibit 163: Quest Diagnostics Inc. – Overview
- Exhibit 164: Quest Diagnostics Inc. – Business segments
- Exhibit 165: Quest Diagnostics Inc. – Key offerings
- Exhibit 166: Quest Diagnostics Inc. – Segment focus
- 12.17 Thermo Fisher Scientific Inc.
- Exhibit 167: Thermo Fisher Scientific Inc. – Overview
- Exhibit 168: Thermo Fisher Scientific Inc. – Business segments
- Exhibit 169: Thermo Fisher Scientific Inc. – Key news
- Exhibit 170: Thermo Fisher Scientific Inc. – Key offerings
- Exhibit 171: Thermo Fisher Scientific Inc. – Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 172: Inclusions checklist
- Exhibit 173: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 174: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 175: Research methodology
- Exhibit 176: Validation techniques employed for market sizing
- Exhibit 177: Information sources
- 13.5 List of abbreviations
- Exhibit 178: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio